Brain Peptide Therapy Reverses Memory Loss in Alzheimer's Disease Models
New peptide delivery system restores brain connections and memory function in Alzheimer's models, offering hope for treating cognitive decline.
635 articles in this topic
New peptide delivery system restores brain connections and memory function in Alzheimer's models, offering hope for treating cognitive decline.
SOMCL-668 improved memory and reduced brain damage in Alzheimer's mice by targeting sigma-1 receptors and protective pathways.
New drug FP802 disrupts toxic brain signaling, preventing memory loss and brain damage in Alzheimer's mouse models.
New research reveals how a single gene defect causes brain changes resembling multiple neurodegenerative diseases simultaneously.
New research reveals how TSC2 mutations suppress translation of autism and epilepsy genes, offering potential therapeutic targets.
Scientists identify ferroptosis as a key driver of Alzheimer's disease, opening doors to iron-based prevention therapies.
Comprehensive review of TSC reveals mTOR inhibitor successes while identifying critical unmet needs in neuropsychiatric care.
New review reveals vascular cognitive impairment contributes to 75% of dementia cases and shares pathways with cardiovascular disease.
Malaysian study shows mindfulness breathing meditation significantly improves cognitive flexibility and reduces stress in just 4 weeks.
New research reveals HRV analysis can detect autonomic dysfunction in sleep apnea and COPD patients, offering a non-invasive screening tool.
Large-scale genetic analysis reveals specific microbes linked to brain regions controlling mood and cognition.
Gut metabolite urolithin A dramatically reduced anxiety in rodent models by fixing mitochondrial dysfunction in brain reward circuits.